News
Media
Conferences
Partners
Publications
Events
CME/CE
Resources
PBM Directory
Subscribe

Spotlight -

Spain has healthcare lessons for the U.S.|

DTC drug sales|

2025 Fall Clinical Dermatology|

AMCP Nexus 2025|

Robert Rouse, Head of US Market Access, CSL Behring

Articles by Robert Rouse, Head of US Market Access, CSL Behring

The value of Innovative Medicine: The clinical and economic impact of the first gene therapy for hemophilia B

ByAmbrose Carrejo, PharmD ,Pharmaceutical Contracting Leader, Kaiser Permanente (retired),Robert Rouse, Head of US Market Access, CSL Behring

November 27th 2023

Latest Updated Articles

Trending on Managed Healthcare Executive

What IRA drug prices will mean for PBMs, health plans and patients

Biosimilar competition could surpass IRA-negotiated savings by year three

Catheter ablation shows benefits for patients with both aFib and sleep apnea

Ultra-processed foods linked to early-onset colorectal adenomas in women

Looking ahead: What the MHE 2025 State of the Industry survey tells us about 2026

© 2025 MJH Life Sciences^®

All rights reserved.